Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
119.7 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR Pierre jean MARTIN
SISA KAZ SANTE BASSE TERRE 109 RUE AUGUSTIN ARCHAMBAUD, 97410 ST PIERRE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of neurosurgery · 2016
OBJECT Radiation necrosis (RN), or its imaging equivalent, treatment-related imaging changes (TRIC), is an inflammatory reaction to high-dose radiation in the brain. The authors sought to investigate the hypothesis that immunotherapy increases the risk of developing RN/TRIC after stereotactic Gamma Knife (GK) radiosurgery for brain metastases. METHODS A total of 180 patients who underwent GK surgery for brain metastases between 2006 and 2012 were studied. The systemic therapy they received was classified as cytotoxic chemotherapy (CT), targeted therapy (TT), or immunotherapy (IT). The timing of systemic therapy in relation to GK treatment was also recorded. Logistic regression was used to calculate the odds of developing RN according to type of systemic therapy received. RESULTS The median follow-up time was 11.7 months. Of 180 patients, 39 (21.7%) developed RN/TRIC. RN/TRIC rates were 37.5% (12 of 32) in patients who received IT alone, 16.9% (14 of 83) in those who received CT only, and 25.0% (5 of 20) in those who received TT only. Median overall survival was significantly longer in patients who developed RN/TRIC (23.7 vs 9.9 months, respectively). The RN/TRIC rate was increased significantly in patients who received IT alone (OR 2.40 [95% CI 1.06–5.44]; p = 0.03), whereas receipt of any CT was associated with a lower risk of RN/TRIC (OR 0.38 [95% CI 0.18–0.78]; p = 0.01). The timing of development of RN/TRIC was not different between patients who received IT and those who received CT. CONCLUSIONS Patients who receive IT alone may have an increased rate of RN/TRIC compared with those who receive CT or TT alone after stereotactic radiosurgery, whereas receiving any CT may in fact be protective against RN/TRIC. As the use of immunotherapies increases, the rate of RN/TRIC may be expected to increase compared with rates in the chemotherapy era.
Annals of the rheumatic diseases · 2021
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
The pharmacogenomics journal · 2026 · Journal Article
Khasru MR, Abdul Jalil NA, Nair N, Barton A, et al.
Journal of cancer education : the official journal of the American Association for Cancer Education · 2025 · Journal Article
Beddok A, Bouazzi L, Barbe C, Martin P, et al.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2023 · Journal Article
Sharma A, Martin PR, Rodriguez FR
The Journal of clinical investigation · 2021 · Journal Article
Kong X, Zeng D, Wu X, Wang B, et al.
JAAD case reports · 2020 · Journal Article
Schwartzberg HG, Bourgeois A, Souers A, Atkinson J, et al.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020 · Journal Article
Hamilton BK, Storer BE, Wood WA, Pidala JA, et al.
Annals of the rheumatic diseases · 2019 · Journal Article
Martin P, Ding J, Duffus K, Gaddi VP, et al.
Journal of neurosurgery · 2016 · Journal Article
Colaco RJ, Martin P, Kluger HM, Yu JB, et al.
BMC cell biology · 2015 · Journal Article
Martin PJ, Haren N, Ghali O, Clabaut A, et al.
Genome biology · 2025 · Journal Article
Shi C, Zhao D, Butler J, Frantzeskos A, et al.
Genome biology · 2021 · Journal Article
Ge X, Frank-Bertoncelj M, Klein K, McGovern A, et al.
The Journal of investigative dermatology · 2021 · Journal Article
Shi C, Ray-Jones H, Ding J, Duffus K, et al.
Expert review of pharmacoeconomics & outcomes research · 2022 · Journal Article
Frappier J, Krelenbaum M, Villalba E, Martin P, et al.
Environmental health perspectives · 2018 · Journal Article
Martin P, Bladier C, Meek B, Bruyere O, et al.
The Yale journal of biology and medicine · 2015 · Case Reports
Colaco R, Martin P, Chiang V
The British journal of developmental psychology · 2025 · Journal Article
Martin P, Speranza M, Colombel F
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017 · Case Reports
Riquin E, Martin P, Duverger P, Menei P, et al.
Archives of rheumatology · 2023 · Journal Article
Costa M, Jorge I, Martin P, Nisihara R, et al.
Advances in rheumatology (London, England) · 2019 · Journal Article
Azevedo PM, Sanson ES, Skare TL, Dos Santos TAFG, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Jalil NAA, Chinoy H, Jani M, Barton A, et al.
Annals of the rheumatic diseases · 2021 · Journal Article
López-Isac E, Smith SL, Marion MC, Wood A, et al.
World journal of clinical cases · 2015 · Case Reports
Fabrizi F, Cresseri D, Fogazzi GB, Moroni G, et al.
Nutrients · 2022 · Observational Study
Martin P, Botsen D, Brugel M, Bertin E, et al.
Cancers · 2023 · Journal Article
Thomssen C, Vetter M, Kantelhardt EJ, Meisner C, et al.
JMIR mHealth and uHealth · 2018 · Journal Article
Nguyen AD, Frensham LJ, Wong MX, Meslin SM, et al.
Environmental microbiome · 2025 · Journal Article
Sussfeld D, Lannes R, Corel E, Bernard G, et al.
Cellular & molecular immunology · 2021 · Journal Article
Martín P, Blanco-Domínguez R, Sánchez-Díaz R
Expert review of pharmacoeconomics & outcomes research · 2022 · Journal Article
Frappier J, Krelenbaum M, Villalba E, Martin P, et al.
Genome biology · 2016 · Journal Article
McGovern A, Schoenfelder S, Martin P, Massey J, et al.